Skip to main content
Figure 1 | Orphanet Journal of Rare Diseases

Figure 1

From: The clinical relevance of outcomes used in late-onset Pompe disease: can we do better?

Figure 1

6MWD in healthy adults and late-onset Pompe patients (untreated and those receiving treatment) [[37]]. 6MWD in healthy adults (black dot) [17], untreated late-onset Pompe patients (red line, data extracted from van der Ploeg et al. [18]), and across several studies of Pompe patients receiving alglucosidase alfa treatment [12–14, 18, 31, 32, 35]. Adapted with permission from [37] © 2013, Springer Science + Business Media. 6MWD, 6-minute walking test distance.

Back to article page